Physician profile
Ian Leopold
NPI 1245723709
$2,208.25
in general payments reported to CMS, 2019-2025
8 companies · $1,310 in 2025
The $1,310 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $337 · 2022: $285 · 2024: $277 · 2025: $1,310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $897 · Food and Beverage: $689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $896.85 |
| Food and Beverage | $689.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,258.90 | 2024-2025 | Icefx Cryoablation System, Axios, Embold Fibered |
| Inari Medical, INC. | $444.70 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Becton, Dickinson and Company | $144.92 | 2024 | Lutonix Drug Coated Balloon |
| Terumo Medical Corporation | $115.10 | 2022 | |
| Biogen, INC. | $100.00 | 2021 | |
| Trisalus Life Sciences, INC. | $76.85 | 2024-2025 | Trinav Infusion System |
| Stryker Corporation | $42.84 | 2025 | Flowtriever |
| Sirtex Medical INC | $24.94 | 2025 | Sir-Spheres Microspheres |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Leopold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.